Creation of a “Wisconsin Index” Nomogram to Predict the Likelihood of Additional Hyperfunctioning Parathyroid Glands During Parathyroidectomy

Objective:The aim of our study was to create a preoperative “index” that could predict the likelihood of additional hyperfunctioning parathyroid glands and let the surgeon determine whether to wait for the intraoperative parathyroid hormone (ioPTH) or to explore further. Background:During parathyroidectomy for primary hyperparathyroidism (PHPT), discovering a minimally “enlarged” parathyroid gland creates a dilemma for the surgeon regarding the need for further exploration. Although ioPTH testing can potentially solve this problem after a 20- to 30-minute period, several surgeons recognize that further operative exploration may be more effective. Methods:We analyzed a prospective database of 1235 consecutive patients who underwent parathyroidectomy for PHPT at our institution between March 2001 and August 2010. The Wisconsin Index (WIN) was defined as the multiplication of preoperative serum calcium by preoperative parathyroid hormone (PTH). Patients were divided into 3 WIN categories: low (<800), medium (801–1600), and high (>1600). The utility of the WIN was then validated on a subsequent cohort of 216 patients. Results:The median age of the patients was 61 years (range, 10–91), and 77% of the patients were female. The mean preoperative calcium and PTH levels were 11.0 ± 0 mg/dL and 127 ± 3 pg/mL, respectively. The mean WIN for the entire cohort was 1461 ± 38 and highly correlated with gland weight (P < 0.000001). A single adenoma was identified in 1000 patients (81%), double adenoma in 100 patients (8%), and hyperplasia in 135 patients (11%). The mean gland weights for the 3 WIN catagories were low = 370 ± 33 mg, medium = 532 ± 39 mg, and high = 985 ± 28 mg, respectively (P < 0.000001). A WIN nomogram, consisting of the combination of WIN and parathyroid gland weight, accurately predicted the likelihood of additional hyperfunctioning parathyroid glands. For example, for a WIN of less than 800 and a gland weight of 500 mg, there is a 9% chance for additional hyperfunctioning parathyroid glands based on the WIN nomogram. In contrast, for the same gland weight, if the WIN is 801 to 1600, these chances increase to 28%, and if the WIN is more than 1600, the chance of multigland disease is 61%. Comparison between the predicted chances for another gland with the actual chance in the validation cohort identified an R2 value of 0.96. Conclusions:The WIN nomogram predicts the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. This simple intraoperative tool may be used to guide the decision of whether to wait for ioPTH results or to proceed with further neck exploration.

[1]  Herb Chen,et al.  A Rising IoPTH Level Immediately After Parathyroid Resection: Are Additional Hyperfunctioning Glands Always Present? An Application of the Wisconsin Criteria , 2010, Annals of surgery.

[2]  M. Guerrero,et al.  Bilateral Neck Exploration in Primary Hyperparathyroidism—When Is It Selected and How Is It Performed? , 2009, World Journal of Surgery.

[3]  E. Chin,et al.  Correlation of Intraoperative Parathyroid Hormone Levels With Parathyroid Gland Size , 2007, The Laryngoscope.

[4]  C. Bieglmayer,et al.  A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. , 2007, Surgery.

[5]  H. van Toor,et al.  Novel criteria for parathyroid hormone levels in parathyroid hormone-guided parathyroid surgery. , 2007, Archives of pathology & laboratory medicine.

[6]  R. Burney,et al.  Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. , 2006, Surgery.

[7]  Q. Duh,et al.  Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. , 2006, Archives of surgery.

[8]  Herb Chen,et al.  Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. , 2005, Surgery.

[9]  Herb Chen,et al.  A Comprehensive Evaluation of Perioperative Adjuncts During Minimally Invasive Parathyroidectomy: Which Is Most Reliable? , 2005, Annals of surgery.

[10]  D. Farley,et al.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. , 2005, Archives of surgery.

[11]  G. Irvin,et al.  Quick Intraoperative Parathyroid Hormone Assay: Surgical Adjunct to Allow Limited Parathyroidectomy, Improve Success Rate, and Predict Outcome , 2004, World Journal of Surgery.

[12]  G. Irvin,et al.  Progress in the Operative Management of Sporadic Primary Hyperparathyroidism Over 34 Years , 2004, Annals of surgery.

[13]  G. Irvin,et al.  Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? , 2003, Surgery.

[14]  Herb Chen.  Surgery for primary hyperparathyroidism: what is the best approach? , 2002, Annals of surgery.

[15]  B. Barraclough,et al.  Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. , 2002, Archives of surgery.

[16]  R. Udelsman.  Six Hundred Fifty-Six Consecutive Explorations for Primary Hyperparathyroidism , 2002, Annals of surgery.

[17]  D. Farley,et al.  The predictive value of laboratory findings in patients with primary hyperparathyroidism. , 2002, Journal of the American College of Surgeons.

[18]  P. Lindblom,et al.  Measurement of intraoperative parathyroid hormone predicts long-term operative success. , 2002, Archives of surgery.

[19]  G. Irvin.  Presidential address: Chasin' hormones , 1999 .

[20]  G. Irvin.  American Association of Endocrine Surgeons. Presidential address: chasin' hormones. , 1999, Surgery.

[21]  G. Sfakianakis,et al.  Ambulatory parathyroidectomy for primary hyperparathyroidism. , 1996, Archives of surgery.

[22]  S. Chandarlapaty,et al.  A New Approach to Parathyroidectomy , 1994, Annals of surgery.

[23]  S. Khosla,et al.  Clinical performance of parathyroid hormone immunometric assays. , 1992, Mayo Clinic proceedings.

[24]  S. Hamburger,et al.  Can the volume of abnormal parathyroid tissue be predicted by preoperative biochemical measurement? , 1987, Surgery.

[25]  C. G. Thomas,et al.  The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism. , 1985, Surgery.